Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

Thalidomide neuropathy

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ochonisky, S., Verroust, J., Bastuji-Garin, S., Gheradi, R. & Revuz J. Thalidomide neuropathy Incidence and clinicoelectrophysiologic findings in 42 patients. Arch. Dermatol. 130, 66–69 (1994).

    Article  CAS  Google Scholar 

  2. Gershon, D. Finding new uses for thalidomide. Nature Med. 1, 1230 (1995).

    Article  CAS  Google Scholar 

  3. Sjostrom, H. & Nilsson, R. Thalidomide and the Power of the Drug Companies. 112–130 (Penguin Books, Harmondsworth, Middlesex, England 1972).

    Google Scholar 

  4. Powell, R.J. & Gardner Medwin, J.M.M. Guideline for the clinical use and dispensing of thalidomide. Postgrad. Med. J. 70, 901–904 (1994).

    Article  CAS  Google Scholar 

  5. Crawford, C.L. Use of thalidomide in leprosy. Adverse Drug React. Toxicol. Rev. 13, 177–192 (1994).

    CAS  PubMed  Google Scholar 

  6. Thalidomide: The drug that came back. First Tuesday; June 1, Yorkshire Television (1993).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crawford, C. Thalidomide neuropathy. Nat Med 2, 132 (1996). https://doi.org/10.1038/nm0296-132b

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0296-132b

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing